Welcome to ASGCT and Viralgen Vector Core.
Viralgen is a CDMO that specializes in development through large-scale commercial production of cGMP certified rAAV for cell and gene therapies. Through our proprietary Pro10™ suspension manufacturing platform, we deliver industry-leading titers for all AAV serotypes to our client partners, optimizing speed to market and cost-of-goods to accelerate clinical development and commercialization. The company’s state-of-the-art facilities based in San Sebastian, Spain include a commercial facility consisting of three modules, each having three cGMP suites with capacities of >2,000 L.